Results 61 to 70 of about 9,354,751 (270)

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Pediatric Patients: An ARChiVe Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the 2022 American College of Rheumatology (ACR)/EULAR classification criteria for antineutrophil cytoplasmic antibody–associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods A cohort of 574 patients, identified by physician's diagnosis (MD‐diagnosis) in A Registry of Childhood Vasculitis, was ...
David A. Cabral   +41 more
wiley   +1 more source

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort

open access: yesFrontiers in Immunology, 2022
ObjectivesThe aim of this study is to investigate the clinical significance of myeloperoxidase (MPO)–antineutrophil cytoplasmic antibody (ANCA) on eosinophilic granulomatosis with polyangiitis (EGPA) from a longitudinal Chinese cohort.MethodsA total of ...
Suying Liu   +9 more
doaj   +1 more source

KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.

open access: yesKidney International
The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA) – Associated Vasculitis represents a focused update of the ANCA-Associated Vasculitis chapter from the
J. Floege   +4 more
semanticscholar   +1 more source

Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features, and mortality.

open access: yesRheumatology, 2022
OBJECTIVE To evaluate the prevalence, clinical and radiographic features, and long-term outcomes of interstitial lung disease (ILD) in a United States-based ANCA-associated vasculitis (AAV) cohort.
B. Doliner   +5 more
semanticscholar   +1 more source

ANCA-associated renal vasculitis [PDF]

open access: yesKidney International, 2002
To the Editor: The Nephrology Forum discussed by Professor Savage reminded us of two items about ANCA-associated renal vasculitis (AARV): (1) the complex pathogenesis, where ANCA are much but not enough; and (2) the role of cytokines1.
Campo A, Grill A, STRATTA, Piero
openaire   +2 more sources

Updates in ANCA-associated vasculitis

open access: yesEuropean Journal of Rheumatology, 2022
Antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) are small-vessel vasculitides that include granulomatosis with polyangiitis (formerly Wegener’s granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (Churg - Strauss syndrome). Renal-limited AAV can be considered a fourth entity. Despite their
Carolyn Ross   +2 more
openaire   +3 more sources

Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Low copy number (CN) of complement C4 isoforms and high CN of retroviral HERV‐K elements are known risk factors for many immune‐mediated inflammatory diseases (IMIDs), often showing sex‐biased effects. Here, we assessed whether CN variation within the C4 gene contributes to giant cell arteritis (GCA) and IgA vasculitis (IgAV), two complex ...
Laura Martínez‐Gutiérrez   +295 more
wiley   +1 more source

Complement in ANCA-Associated Vasculitis

open access: yesSeminars in Nephrology, 2013
Antineutrophil cytoplasmic autoantibodies (ANCA) are the likely cause for necrotizing small vessel vasculitis and crescentic glomerulonephritis. Unlike other forms of crescentic glomerulonephritis induced by immune complexes or anti-glomerular basement membrane (anti-GBM) antibodies that have conspicuous vessel wall immunoglobulin and complement, there
J, Charles Jennette   +2 more
openaire   +3 more sources

Long-term patient survival in ANCA-associated vasculitis.

open access: yes, 2010
Wegener's granulomatosis and microscopic polyangiitis are antineutrophil cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. The long-term survival of patients with ANCA associated vasculitis treated with current
Rasmussen, N   +74 more
core   +1 more source

A case of COVID‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy

open access: yesClinical Case Reports
Key Clinical Message Both C‐anti‐neutrophil cytoplasmic antibody (ANCA) and P‐ANCA vasculitis were reported to be associated with COVID‐19 infection. The ideal management of COVID‐19‐associated ANCA vasculitis is unclear, as the experiences were limited ...
Michael Filoramo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy